Predict your next investment

Venture Capital
xeraya.com

See what CB Insights has to offer

Investments

26

Portfolio Exits

5

About Xeraya Capital

Xeraya Capital focuses its activities, expertise, and resources focus solely on the Life Sciences sector. The firm looks to generate superior investment returns by cultivating value over the long-term.

Xeraya Capital Headquarter Location

26.03 – 26.08 Level 26 G Tower, 199 Jalan Tun Razak

Kuala Lumpur, 50400,

Malaysia

+603 2381 8700

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Xeraya Capital

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Xeraya Capital in 1 Expert Collection, including Synthetic Biology.

S

Synthetic Biology

382 items

Latest Xeraya Capital News

OncoMyx Closes $50M Series B

Dec 8, 2021

PHOENIX, AZ, OncoMyx Therapeutics, a privately-held immuno-oncology platform company, announced the closing of a $50 million Series B financing, co-led by Lumira Ventures and B Capital Group with participation from LYZZ Capital and all Series A investors: Boehringer Ingelheim Venture Fund, Delos Capital, Xeraya Capital, Korea Investment Partners, City Hill Ventures, and Madison Partners. OncoMyx Therapeutics, a startup launched from Arizona State University (ASU), develops oncolytic immunotherapies based on the myxoma virus (MYXV) platform to orchestrate an immune response and treat cancer. Successful immuno-oncology (IO) cancer treatment generally requires combination therapy, and oncolytic viruses (OVs) have emerged as a safe and effective IO complement. The company's MYXV platform, spun out from ASU, is poised to be a best-in-class OV approach, and the top OV team has assembled around MYXV to create important new therapeutic options for cancer patients. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.

Xeraya Capital Investments

26 Investments

Xeraya Capital has made 26 investments. Their latest investment was in Aria CV as part of their Unattributed VC on July 7, 2022.

CBI Logo

Xeraya Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/18/2022

Unattributed VC

Aria CV

$7.77M

No

1

2/3/2022

PIPE

Greenlight Biosciences

$105M

No

1

12/8/2021

Series B

OncoMyx

$50M

No

17

11/19/2020

Series C

Subscribe to see more

$99M

Subscribe to see more

10

11/9/2020

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/18/2022

2/3/2022

12/8/2021

11/19/2020

11/9/2020

Round

Unattributed VC

PIPE

Series B

Series C

Series C

Company

Aria CV

Greenlight Biosciences

OncoMyx

Subscribe to see more

Subscribe to see more

Amount

$7.77M

$105M

$50M

$99M

$99M

New?

No

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

1

17

10

10

Xeraya Capital Portfolio Exits

5 Portfolio Exits

Xeraya Capital has 5 portfolio exits. Their latest portfolio exit was Greenlight Biosciences on February 03, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

2/3/2022

Reverse Merger

$99M

3

7/16/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

7/16/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

8/6/2020

IPO

Subscribe to see more

$99M

Subscribe to see more

10

10/25/2017

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

2/3/2022

7/16/2021

7/16/2021

8/6/2020

10/25/2017

Exit

Reverse Merger

IPO

IPO

IPO

Acquired

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

3

10

10

10

10

Xeraya Capital Team

1 Team Member

Xeraya Capital has 1 team member, including current Investment Partner, Aditya Puri.

Name

Work History

Title

Status

Aditya Puri

Investment Partner

Current

Name

Aditya Puri

Work History

Title

Investment Partner

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.